KR20130094280A - 토브라마이신과 덱사메타손을 함유하는 국소 안과 현탁액 - Google Patents

토브라마이신과 덱사메타손을 함유하는 국소 안과 현탁액 Download PDF

Info

Publication number
KR20130094280A
KR20130094280A KR1020137000258A KR20137000258A KR20130094280A KR 20130094280 A KR20130094280 A KR 20130094280A KR 1020137000258 A KR1020137000258 A KR 1020137000258A KR 20137000258 A KR20137000258 A KR 20137000258A KR 20130094280 A KR20130094280 A KR 20130094280A
Authority
KR
South Korea
Prior art keywords
composition
viscosity
xanthan gum
tobramycin
sodium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
KR1020137000258A
Other languages
English (en)
Korean (ko)
Inventor
바그와티 피 카브라
Original Assignee
알콘 리서치, 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 알콘 리서치, 리미티드 filed Critical 알콘 리서치, 리미티드
Publication of KR20130094280A publication Critical patent/KR20130094280A/ko
Abandoned legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts, ocular implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
KR1020137000258A 2010-06-23 2010-06-23 토브라마이신과 덱사메타손을 함유하는 국소 안과 현탁액 Abandoned KR20130094280A (ko)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2010/039618 WO2011162752A1 (en) 2010-06-23 2010-06-23 Topical ophthalmic suspensions containing tobramycin and dexamethasone

Publications (1)

Publication Number Publication Date
KR20130094280A true KR20130094280A (ko) 2013-08-23

Family

ID=44080140

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020137000258A Abandoned KR20130094280A (ko) 2010-06-23 2010-06-23 토브라마이신과 덱사메타손을 함유하는 국소 안과 현탁액

Country Status (10)

Country Link
EP (1) EP2585037A1 (enExample)
JP (1) JP5728082B2 (enExample)
KR (1) KR20130094280A (enExample)
CN (1) CN102946855B (enExample)
AU (1) AU2010356098B2 (enExample)
BR (1) BR112012033052A2 (enExample)
CA (1) CA2801731A1 (enExample)
MX (1) MX2012015051A (enExample)
WO (1) WO2011162752A1 (enExample)
ZA (1) ZA201209240B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201208080D0 (en) * 2012-05-09 2012-06-20 Norton Healthcare Ltd Tobramycin formulation
JP6527315B2 (ja) * 2014-08-08 2019-06-05 Ｄｓｐ五協フード＆ケミカル株式会社 速溶性増粘剤、咀嚼・嚥下困難者用増粘剤及び咀嚼・嚥下困難者用飲食品
CN109260219B (zh) * 2018-11-30 2021-03-09 山东省药学科学院 一种关节腔注射制剂及其应用
IT202000002296A1 (it) * 2020-02-06 2021-08-06 Sifi Spa Formulazioni topiche oftalmiche a base di xantano con ridotta posologia
US12472216B2 (en) * 2020-05-12 2025-11-18 Probiotical S.P.A. Compositions comprising bacterial strains and use thereof for the treatment of ocular diseases and lesions
IT202200000821A1 (it) * 2022-01-19 2023-07-19 Sifi Spa Formulazioni topiche oftalmiche a base di xantano con ridotta posologia
CN115006412B (zh) * 2022-05-20 2023-11-10 北京诺康达医药科技股份有限公司 一种复方妥布霉素滴眼液及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4136177A (en) 1977-01-31 1979-01-23 American Home Products Corp. Xanthan gum therapeutic compositions
US5149694A (en) 1988-03-09 1992-09-22 Alcon Laboratories, Inc. Combination of tobramycin and dexamethasone for topical ophthalmic use
DK1348427T3 (da) * 1997-07-29 2008-06-30 Alcon Lab Inc Oftalmiske sammensætninger indeholdende galactomannanpolymerer og borater
KR100598722B1 (ko) * 1998-04-07 2006-07-11 알콘 래보레이토리스, 인코퍼레이티드 잔탄 검을 포함하는 겔화 안과용 조성물
US6261547B1 (en) 1998-04-07 2001-07-17 Alcon Manufacturing, Ltd. Gelling ophthalmic compositions containing xanthan gum
US6174524B1 (en) 1999-03-26 2001-01-16 Alcon Laboratories, Inc. Gelling ophthalmic compositions containing xanthan gum
EP1305033B1 (en) 2000-07-28 2004-10-20 Alcon, Inc Pharmaceutical compositions containing tobramycin and xanthan gum

Also Published As

Publication number Publication date
CA2801731A1 (en) 2011-12-29
CN102946855B (zh) 2016-01-06
JP2013529632A (ja) 2013-07-22
AU2010356098B2 (en) 2014-08-14
MX2012015051A (es) 2013-02-15
BR112012033052A2 (pt) 2019-09-24
CN102946855A (zh) 2013-02-27
AU2010356098A1 (en) 2013-01-10
WO2011162752A1 (en) 2011-12-29
JP5728082B2 (ja) 2015-06-03
ZA201209240B (en) 2014-02-26
EP2585037A1 (en) 2013-05-01

Similar Documents

Publication Publication Date Title
US8450287B2 (en) Topical ophthalmic compositions containing tobramycin and dexamethasone
KR20130094280A (ko) 토브라마이신과 덱사메타손을 함유하는 국소 안과 현탁액
CA2760140C (en) Topical solution formulations containing a corticosteroid and a cyclodextrin
JP2025031918A (ja) ジクアホソルまたはその塩、およびポリビニルピロリドンを含有する水性眼科用組成物
US20070110812A1 (en) Ophthalmic composition for dry eye therapy
JP3043795B2 (ja) 蛋白質ゲル状眼用賦形剤
US5366985A (en) Method for preparation of an aqueous suspension
JP2808378B2 (ja) 水性懸濁液剤の製造法
EP2758031A1 (en) Ophthalmic gel compositions
US20080306039A1 (en) Loteprednol Etabonate Aqueous Suspension
EP1647273A1 (en) Ophthalmic composition
US4623664A (en) Oil suspended phenylephrine
CA2835013C (en) Eye drops for treatment of conjunctivochalasis
WO2024092085A1 (en) Aqueous pharmaceutical compositions of prostaglandins
WO2022238251A2 (en) Ophthalmic pharmaceutical composition comprising atropine
EP4580600A1 (en) Ophthalmic compositions
US20060094700A1 (en) Heat sterilization of a steroid in the presence of phosphate
CN116847826A (zh) 包含左氧氟沙星和酮咯酸的眼用组合物、其制备方法和用途
EP4088714A1 (en) Ophthalmic pharmaceutical composition comprising atropine
MXJL05000034A (es) Una formulacion oftalmica topica y su uso.

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20130104

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20150522

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20160630

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20161220

PC1904 Unpaid initial registration fee